ACRIX | CRAAX | ACRIX / CRAAX | |
Total Expense Ratio | 1.18 | 1.06 | 111% |
Annual Report Gross Expense Ratio | 1.18 | 1.06 | 111% |
Fund Existence | 9 years | 13 years | - |
Gain YTD | 1.660 | 4.092 | 41% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 10000000 | 2000 | 500,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.32B | 2.4B | 55% |
Annual Yield % from dividends | 0.54 | 2.21 | 24% |
Returns for 1 year | -4.86 | 7.03 | -69% |
Returns for 3 years | 19.32 | 19.44 | 99% |
Returns for 5 years | 37.68 | 10.50 | 359% |
Returns for 10 years | N/A | 22.17 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETAHX | 32.69 | -0.22 | -0.67% |
Eventide Healthcare & Life Sciences A | |||
REIGX | 16.34 | -0.16 | -0.97% |
Federated Hermes International Growth R6 | |||
CFNAX | 84.07 | -0.94 | -1.11% |
American Funds Fundamental Invs 529A | |||
JANWX | 117.43 | -1.53 | -1.29% |
Janus Henderson Global Research D | |||
EAFGX | 27.31 | -0.36 | -1.30% |
Eaton Vance Focused Growth Opps A |